IPDN Q2 2023 Earnings Net Loss of 014 Per Share Reflects Ongoing Investment Phase Vera Therapeutics Q1 2026 Earnings EPS Miss Highlights PreRevenue Stage Challenges Beazer Homes BZH Q1 2026 Earnings Surprise EPS Beat Defies Expectations MCRI Q1 2026 Earnings EPS Surges Past Estimates by 349 DTIL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Advances Pipeline BCYC Q1 2026 Earnings WiderThanExpected Loss But Shares Edge Higher